SCHEMBL5011835

SCHEMBL5011835

Cc1cccc(C(=O)N2N(Cc3ccc(C(F)(F)F)cc3)C(=O)OC23CCCCC3)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
POLB P06746 2/20 0.39
TP53 P04637 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 2/20 0.39
MDM2 Q00987 5/20 0.38
PRKAB2 O43741 1/20 0.38
PRKAG1 P54619 1/20 0.38
PRKAA2 P54646 1/20 0.38
PRKAA1 Q13131 1/20 0.38
PRKAG3 Q9UGI9 1/20 0.38
PRKAG2 Q9UGJ0 1/20 0.38
PRKAB1 Q9Y478 1/20 0.38
LMNA P02545 2/20 0.38
KCNK3 O14649 1/20 0.37
KCNK9 Q9NPC2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5011747 0.91 KCNK3 (0.40) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL5016329 0.88 CHRM2 (0.43) TP53MAPTHPGDLMNAALDH1A1
SCHEMBL5011651 0.77 CHRM2 (0.44) TP53LMNAALDH1A1KDM4E
SCHEMBL1086170 0.74 EPHX2 (0.46) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL5011879 0.72 KMT2A (0.38) POLBMAPTHPGDLMNAALDH1A1
SCHEMBL5015148 0.72 LMNA (0.45) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL5015165 0.70 ATM (0.47) CYP1A2CYP3A4MAPTHPGDLMNA
SCHEMBL5011708 0.69 CYP1A2 (0.45) CYP1A2CYP2D6CYP2C19TP53MAPT
SCHEMBL5011764 0.69 HTT (0.44) HPGDLMNAALDH1A1THRB
SCHEMBL5013452 0.67 METAP2 (0.37) CYP2D6CYP2C9LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1910381-A2 SUBSTITUTED 1-OXA-3,8-DIAZASPIRO[4.5]-DECAN-2-ON- COMPOUNDS AND THE USE THEREOF FOR PRODUCING DRUGS Grünenthal GmbH (DE) 2008-04-16 EP disclosed
WO-2007000325-A2 SUBSTITUTED 1-OXA-3,8-DIAZASPIRO[4.5]-DECAN-2-ON- COMPOUNDS AND THE USE THEREOF FOR PRODUCING DRUGS Grünenthal GmbH (DE) 2007-01-04 WO disclosed